EUROIMMUN Logo
Find
X

What are you looking for?

Filter for products in our complete portfolio

Product finder

Worldwide
X
Euroimmun worldwide

This website provides an overview of the business activities and products of EUROIMMUN AG worldwide. Not all products are registered and approved in all countries or regions. Please contact your country representative for product availability and information

Euroimmun branches

Choose your country

Europe

North America

South & Central America

Asia

Middle East & Africa

EUROIMMUN Logo

Press releases and articles

High concordance of serological methods for EBV staging

A new collaborative study by Euroimmun and researchers in Türkiye reports that both ELISA and immunoblot show excellent agreement with the reference standard — indirect immunofluorescence assay (IFA) ...

Serological diagnostics of Oropouche virus infections: Euroimmun Brazil launches new ANVISA-approved ELISAs

Climate change, population growth, global travel and shifting lifestyles all increase both how likely and how quickly infectious diseases spread. This is especially true for arboviruses, which are ...

Robust performance of serological tests for coeliac disease in Tunisia

Serological tests for coeliac disease-specific antibodies showed exceptionally high sensitivity and specificity in a Tunisian cohort, underscoring their diagnostic utility. The recently published ...

Euroimmun sets new standards in serological neurological diagnostics

Long anticipated – now available: the neurology portfolio for the UNIQO 160, our all-in-one automated IFA system, has been expanded by nine more indirect immunofluorescence assays (IFA). While the ...

Clarity on the floor: differentiating dermal-binding autoantibodies

A newly published international study has demonstrated the high sensitivity of the Euroimmun Dermal Binder Mosaic 1 for detecting antibodies against laminin β4, laminin 332 and collagen type VII. The ...

Welcome to the Future of Learning: Euroimmun Campus is Live!

The way we learn has changed dramatically in recent years. During the pandemic, online training became essential, and now, we’re taking the next big step to make learning smarter and more efficient. ...

On the trail of anti-laminin β4 autoantibodies

A long-standing research collaboration between Euroimmun and the University of Lübeck, Germany has led to major advances in understanding anti-p200 pemphigoid, a rare autoimmune skin blistering ...

New addition to our dengue test portfolio: Highest specificity for your diagnostics.

Currently, dengue fever poses the greatest challenge in terms of arbovirus infections. With over 14 million cases reported worldwide in 2024, this is the largest ever recorded epidemic of vector-borne ...

Circulating calprotectin – a new promising inflammation parameter

The evaluation of the inflammatory status is crucial for the assessment of disease activity and therapy response in systemic autoimmune rheumatic diseases such as rheumatoid arthritis, systemic ...

Arboviruses: global threat and local reality

Vector-borne diseases such as dengue, chikungunya, Zika and West Nile fever account for more than 17% of all infectious diseases worldwide. According to the World Health Organization (WHO), over 5.6 ...

Page 1 of 13.

Back to top